Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Bleeding Risk Factors in Thrombocytopenic Patients with Hematologic Malignancies

Jacqueline Poston, Siobhan Brown, Amy S Ginsburg, Anton Ilich, Heather Herren, Nahed El Kassar, Christopher Edward Jensen, Darrell J Triulzi, Nigel S. Key, Susanne May, Terry B Gernsheimer

Blood (2023) 142 (Supplement 1): 2667.

https://doi.org/10.1182/blood-2023-186654

Published: 2023

Journal Articles

Initial Report of Part B Phase 1/2 Efficacy and Safety Results for Bruton Tyrosine Kinase Inhibitor Rilzabrutinib in Patients with Relapsed Immune Thrombocytopenia

Nichola Cooper, A.J. Gerard Jansen, Robert Bird, Jiří Mayer, Michelle Sholzberg, Michael D. Tarantino, Mamta Garg, Paula F Ypma, Vickie McDonald, Charles Percy, Milan Košťál, Isaac Goncalves, Lachezar H. Bogdanov, Terry B Gernsheimer, Remco Diab, Mengjie Yao, Ahmed Daak, David J Kuter

Blood (2023) 142 (Supplement 1): 685.

https://doi.org/10.1182/blood-2023-177808

Published: 2023

Journal Articles

Binary Gender Differences in Quality of Life and Social Supports Among Individuals with Immune Thrombocytopenia (ITP): Data from the ITP Natural History Study Registry

Jennifer MacWhirter - DiRaimo, Kevin Won, Caroline Kruse, Terry B Gernsheimer

Blood (2023) 142 (Supplement 1): 2592.

https://doi.org/10.1182/blood-2023-181390

Published: 2023

Journal Articles

Serial HLA-Antibody Testing Identifies Waning Calculated Panel Reactive Antibodies (cPRA) in Platelet Transfusion Refractory Patients with Hematologic Malignancies

Kanak Parmar, Hamilton C Tsang, Danny Youngs, Zach Gill, Rida A. Hasan, Monica B. Pagano, John R. Hess, Terry B. Gernsheimer, Idoia Gimferrer, Sandhya Panch

Blood (2022) 140 (Supplement 1): 8566–8567.

https://doi.org/10.1182/blood-2022-170886

Published: 2022

Journal Articles

Prophylactic tranexamic acid in patients with hematologic malignancy: a placebo-controlled, randomized clinical trial

Terry B. Gernsheimer, Siobhan P. Brown, Darrell J. Triulzi, Nigel S. Key, Nahed El Kassar, Heather Herren, Jacqueline N. Poston, Michael Boyiadzis, Brandi N. Reeves, Subodh Selukar, Monica B. Pagano, Scott Emerson, Susanne May

Blood (2022) 140 (11): 1254–1262.

https://doi.org/10.1182/blood.2022016308

Published: 2022

Includes: Supplemental data

Journal Articles

Absence of Hyperactivation of Fibrinolysis Explains the Lack of Hemostatic Efficacy of Prophylactic Tranexamic Acid (TXA) in Hypoproliferative Thrombocytopenia

Anton Ilich, Terry B. Gernsheimer, Darrell J Triulzi, Heather Herren, Siobhan P Brown, Lori A Holle, Andrew T Lucas, Nahed El Kassar, Alisa S. Wolberg, Susanne May, Nigel S Key

Blood (2021) 138 (Supplement 1): 2094.

https://doi.org/10.1182/blood-2021-146898

Published: 2021

Journal Articles

Durability of Platelet Response When Switching from Eltrombopag or Romiplostim to Avatrombopag in Immune Thrombocytopenia (ITP): A Multicenter Study

Hanny Al-Samkari, Debbie Jiang, Terry B. Gernsheimer, Howard A. Liebman, Susie Lee, Chelsea Bernheisel, Scott Kolodny, Matthew Wojdyla, Michael Vredenburg, Brian Jamieson, Adam Cuker

Blood (2021) 138 (Supplement 1): 1015.

https://doi.org/10.1182/blood-2021-151321

Published: 2021

Journal Articles

Sars-Cov-2 Vaccination in Patients with Pre-Existing Immune Thrombocytopenia

Eun-Ju Lee, Marina Beltrami Moreira, Hanny Al-Samkari, Adam Cuker, Jennifer MacWhirter - DiRaimo, Terry B. Gernsheimer, Alexandra Kruse, Craig M. Kessler, Caroline Kruse, Andrew D Leavitt, Alfred Ian Lee, Howard A. Liebman, Adrian C. Newland, Ashley E. Ray, Michael D Tarantino, Jecko Thachil, David J. Kuter, Douglas B. Cines, James B Bussel

Blood (2021) 138 (Supplement 1): 586.

https://doi.org/10.1182/blood-2021-152918

Published: 2021

Journal Articles

Durability of Initial Platelet Count Response in Patients Treated with Avatrombopag for Immune Thrombocytopenia (ITP): Post-Hoc Results from a Phase 3 Clinical Study

Shivi Jain, MDMBBS, Matthew Wojdyla, PharmD, Michael Vredenburg, PhD, Brian Jamieson, MDBA, Terry B. Gernsheimer, MD

Blood (2020) 136 (Supplement 1): 22–23.

https://doi.org/10.1182/blood-2020-142764

Published: 2020

Journal Articles

Effects of Tranexamic Acid Prophylaxis on Bleeding Outcomes in Hematologic Malignancy: The a-TREAT Trial

Terry B. Gernsheimer, MD, Siobhan P Brown, PhD, Darrell J Triulzi, MD, Nigel S. Key, MD, Nahed El Kassar, MD PhD, Heather Herren, RN, MPH, Susanne May, PhD

Blood (2020) 136 (Supplement 1): 1–2.

https://doi.org/10.1182/blood-2020-138920

Published: 2020

Journal Articles

Retrospective Evaluation of the Use of Romiplostim after Hematopoietic Stem Cell Transplantation0

Elisabetta Xue, MD, Tatiana Lawrence, MD, Terry B. Gernsheimer, MD, Filippo Milano, MD PhD

Blood (2019) 134 (Supplement_1): 5660.

https://doi.org/10.1182/blood-2019-128673

Published: 2019

Journal Articles

Comparison of Outcomes after Early Hospital Discharge (EHD) Following Intensive Induction Vs. Post-Remission Chemotherapy for Adults with Acute Myeloid Leukemia (AML) and Other High-Grade Myeloid Neoplasms

Anna B. Halpern, MD, Nicholas P Howard, Megan Othus, PhD, Paul C. Hendrie, MD PhD, Nikita Vashi Baclig, MD MPH, Sarah A Buckley, MD, Mary-Elizabeth M. Percival, MD, Pamela S. Becker, MD PhD, Bart L. Scott, MD, Vivian G. Oehler, MD, Terry B. Gernsheimer, MD, Sioban B. Keel, MD, Johnnie Orozco, MD, Ryan D. Cassaday, MD, Andrei R Shustov, MD, Garrett Hartley, Verna L Welch, PhD MPH, Elihu H. Estey, MD, Roland B. Walter, MD PhD MS

Blood (2019) 134 (Supplement_1): 1317.

https://doi.org/10.1182/blood-2019-124586

Published: 2019

Journal Articles

Comparative Analysis of Patterns of Infectious Complications of Outpatient Vs. Inpatient Care Following Intensive Induction Chemotherapy for Adults with Acute Myeloid Leukemia (AML) or Other High-Grade Myeloid Neoplasms

Anna B. Halpern, MD, Nicholas P Howard, Megan Othus, PhD, Paul C. Hendrie, MD PhD, Nikita Vashi Baclig, MD MPH, Sarah A Buckley, MD, Mary-Elizabeth M. Percival, MD, Pamela S. Becker, MD PhD, Bart L. Scott, MD, Vivian G. Oehler, MD, Terry B. Gernsheimer, MD, Sioban Keel, MD, Johnnie Orozco, MD, Ryan D. Cassaday, MD, Andrei R Shustov, MD, Garrett Hartley, Verna L Welch, PhD MPH, Elihu H. Estey, MD, Roland B. Walter, MD PhD MS

Blood (2019) 134 (Supplement_1): 1323.

https://doi.org/10.1182/blood-2019-123605

Published: 2019

Journal Articles

Clinical updates in adult immune thrombocytopenia

Michele P. Lambert, Terry B. Gernsheimer

Blood (2017) 129 (21): 2829–2835.

https://doi.org/10.1182/blood-2017-03-754119

Published: 2017

Journal Articles

Phase 2 Study Of Early Discharge and Outpatient Management Of Adult Patients Following Intensive Induction Chemotherapy For MDS and Non-APL AML

Jennifer E. Vaughn, MD, MSPH, Morgan A. Powell, BS, Kelda M. Gardner, PA-C, Megan Othus, PhD, Rajeev Rajendra, MD, PhD, Donnelle Rizutto, RN, Pamela S. Becker, MD, PhD, Paul C. Hendrie, MD, PhD, Andrei R. Shustov, MD, Siobán B. Keel, MD, Vivian G. Oehler, MD, Terry B. Gernsheimer, MD, Janis L. Abkowitz, MD, Elihu H. Estey, MD, Roland B. Walter, MD, PhD

Blood (2013) 122 (21): 2932.

https://doi.org/10.1182/blood.V122.21.2932.2932

Published: 2013

Journal Articles

Integrated Analysis of Long Term Safety in Patients (pts) with Chronic Immune Thrombocytopenia (ITP) Treated with Romiplostim.

Douglas B. Cines, MD, Terry B. Gernsheimer, MD, Jeffrey Wasser, MD, Bertrand Godeau, MD, Andrew Provan, MD, Roger M. Lyons, MD, Ivy Altomare, Xuena Wang, PhD, Paul Woodard, MD

Blood (2012) 120 (21): 2185.

https://doi.org/10.1182/blood.V120.21.2185.2185

Published: 2012

Journal Articles

Antithrombin Concentrate Use in Pediatric Extracorporeal Membrane Oxygenation: A Retrospective Cohort Study

Trisha E. Wong, MD, Meghan Delaney, DO, MPH, Terry B. Gernsheimer, MD, Dana C. Matthews, MD, Tom Brogan, MD, Rob Mazor, MD, D. Michael McMullan, MD, Alexander P Reiner, MD, MSC, Barbara A. Konkle, MD

Blood (2012) 120 (21): 1170.

https://doi.org/10.1182/blood.V120.21.1170.1170

Published: 2012

Journal Articles

Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia

Sarah J. Barsam, Bethan Psaila, Marc Forestier, Lemke K. Page, Peter A. Sloane, Julia T. Geyer, Glynis O. Villarica, Mary M. Ruisi, Terry B. Gernsheimer, Juerg H. Beer, James B. Bussel

Blood (2011) 117 (21): 5723–5732.

https://doi.org/10.1182/blood-2010-11-321398

Published: 2011

Journal Articles

International consensus report on the investigation and management of primary immune thrombocytopenia

Blood (2010) 115 (2): 168–186.

https://doi.org/10.1182/blood-2009-06-225565

Published: 2010

Includes: Supplemental data

Journal Articles

Evaluation of AMG 531 Efficacy in Splenectomized Patients with Chronic Immune Thrombocytopenic Purpura (ITP) in a Randomized Placebo-Controlled Phase 3 Study.

Terry B. Gernsheimer, Vinod Pullarkat, Francis M. Senecal, Louis M. Aledort, Craig M. Kessler, Miguel A. Sanz, Howard A. Liebman, Frank T. Slovick, Reggie Kelly, Matthew Guo, Janet Nichol

Blood (2007) 110 (11): 2.

https://doi.org/10.1182/blood.V110.11.2.2

Published: 2007

NARROW

Bleeding Risk Factors in Thrombocytopenic Patients with Hematologic Malignancies

Initial Report of Part B Phase 1/2 Efficacy and Safety Results for Bruton Tyrosine Kinase Inhibitor Rilzabrutinib in Patients with Relapsed Immune Thrombocytopenia

Binary Gender Differences in Quality of Life and Social Supports Among Individuals with Immune Thrombocytopenia (ITP): Data from the ITP Natural History Study Registry

Serial HLA-Antibody Testing Identifies Waning Calculated Panel Reactive Antibodies (cPRA) in Platelet Transfusion Refractory Patients with Hematologic Malignancies

Prophylactic tranexamic acid in patients with hematologic malignancy: a placebo-controlled, randomized clinical trial

Absence of Hyperactivation of Fibrinolysis Explains the Lack of Hemostatic Efficacy of Prophylactic Tranexamic Acid (TXA) in Hypoproliferative Thrombocytopenia

Durability of Platelet Response When Switching from Eltrombopag or Romiplostim to Avatrombopag in Immune Thrombocytopenia (ITP): A Multicenter Study

Sars-Cov-2 Vaccination in Patients with Pre-Existing Immune Thrombocytopenia

Durability of Initial Platelet Count Response in Patients Treated with Avatrombopag for Immune Thrombocytopenia (ITP): Post-Hoc Results from a Phase 3 Clinical Study

Effects of Tranexamic Acid Prophylaxis on Bleeding Outcomes in Hematologic Malignancy: The a-TREAT Trial

Retrospective Evaluation of the Use of Romiplostim after Hematopoietic Stem Cell Transplantation0

Comparison of Outcomes after Early Hospital Discharge (EHD) Following Intensive Induction Vs. Post-Remission Chemotherapy for Adults with Acute Myeloid Leukemia (AML) and Other High-Grade Myeloid Neoplasms

Comparative Analysis of Patterns of Infectious Complications of Outpatient Vs. Inpatient Care Following Intensive Induction Chemotherapy for Adults with Acute Myeloid Leukemia (AML) or Other High-Grade Myeloid Neoplasms

Clinical updates in adult immune thrombocytopenia

Phase 2 Study Of Early Discharge and Outpatient Management Of Adult Patients Following Intensive Induction Chemotherapy For MDS and Non-APL AML

Integrated Analysis of Long Term Safety in Patients (pts) with Chronic Immune Thrombocytopenia (ITP) Treated with Romiplostim.

Antithrombin Concentrate Use in Pediatric Extracorporeal Membrane Oxygenation: A Retrospective Cohort Study

Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia

International consensus report on the investigation and management of primary immune thrombocytopenia

Evaluation of AMG 531 Efficacy in Splenectomized Patients with Chronic Immune Thrombocytopenic Purpura (ITP) in a Randomized Placebo-Controlled Phase 3 Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only